{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:34:27Z","timestamp":1792805667219,"version":"4.5.0"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"11","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Proton pumps like the vacuolar-type H+ ATPase (V-ATPase) are involved in the control of cellular pH in normal and tumor cells. Treatment with proton pump inhibitors (PPI) induces sensitization of cancer cells to chemotherapeutics via modifications of cellular pH gradients. It is also known that low pH is the most suitable condition for a full PPI activation. Here, we tested whether PPI treatment in unbuffered culture conditions could affect survival and proliferation of human B-cell tumors. First, we showed that PPI treatment increased the sensitivity to vinblastine of a pre-B acute lymphoblastic leukemia (ALL) cell line. PPI, per se, induced a dose-dependent inhibition of proliferation of tumor B cells, which was associated with a dose- and time-dependent apoptotic-like cytotoxicity in B-cell lines and leukemic cells from patients with pre-B ALL. The effect of PPI was mediated by a very early production of reactive oxygen species (ROS), that preceded alkalinization of lysosomal pH, lysosomal membrane permeabilization, and cytosol acidification, suggesting an early destabilization of the acidic vesicular compartment. Lysosomal alterations were followed by mitochondrial membrane depolarization, release of cytochrome c, chromatin condensation, and caspase activation. However, inhibition of caspase activity did not affect PPI-induced cell death, whereas specific inhibition of ROS by an antioxidant (N-acetylcysteine) significantly delayed cell death and protected both lysosomal and mitochondrial membranes. The proapoptotic activity of PPI was consistent with a clear inhibition of tumor growth following PPI treatment of B-cell lymphoma in severe combined immunodeficient mice. This study further supports the importance of acidity and pH gradients in tumor cell homeostasis and suggests new therapeutic approaches for human B-cell tumors based on PPI. [Cancer Res 2007;67(11):5408\u201317]<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-4095","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T18:28:14Z","timestamp":1180722494000},"page":"5408-5417","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":262,"title":["Proton Pump Inhibitors Induce Apoptosis of Human B-Cell Tumors through a Caspase-Independent Mechanism Involving Reactive Oxygen Species"],"prefix":"10.1158","volume":"67","author":[{"given":"Angelo","family":"De Milito","sequence":"first","affiliation":[{"name":"1Department of Drug Research and Evaluation, Pharmacogenetic, Drug Resistance, and Experimental Therapeutic Section;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Iessi","sequence":"additional","affiliation":[{"name":"1Department of Drug Research and Evaluation, Pharmacogenetic, Drug Resistance, and Experimental Therapeutic Section;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariantonia","family":"Logozzi","sequence":"additional","affiliation":[{"name":"1Department of Drug Research and Evaluation, Pharmacogenetic, Drug Resistance, and Experimental Therapeutic Section;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Lozupone","sequence":"additional","affiliation":[{"name":"1Department of Drug Research and Evaluation, Pharmacogenetic, Drug Resistance, and Experimental Therapeutic Section;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Spada","sequence":"additional","affiliation":[{"name":"2Department of Cell Biology, Istituto Superiore di Sanita\u0300, Rome, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lucia","family":"Marino","sequence":"additional","affiliation":[{"name":"1Department of Drug Research and Evaluation, Pharmacogenetic, Drug Resistance, and Experimental Therapeutic Section;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Federici","sequence":"additional","affiliation":[{"name":"1Department of Drug Research and Evaluation, Pharmacogenetic, Drug Resistance, and Experimental Therapeutic Section;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Perdicchio","sequence":"additional","affiliation":[{"name":"1Department of Drug Research and Evaluation, Pharmacogenetic, Drug Resistance, and Experimental Therapeutic Section;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Matarrese","sequence":"additional","affiliation":[{"name":"1Department of Drug Research and Evaluation, Pharmacogenetic, Drug Resistance, and Experimental Therapeutic Section;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Lugini","sequence":"additional","affiliation":[{"name":"1Department of Drug Research and Evaluation, Pharmacogenetic, Drug Resistance, and Experimental Therapeutic Section;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nilsson","sequence":"additional","affiliation":[{"name":"3Microbiology and Tumorbiology Center, Karolinska Institute, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Fais","sequence":"additional","affiliation":[{"name":"1Department of Drug Research and Evaluation, Pharmacogenetic, Drug Resistance, and Experimental Therapeutic Section;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,6,1]]},"reference":[{"key":"2022061623331878100_B1","doi-asserted-by":"crossref","unstructured":"Raghunand N, He X, van Sluis R, et al. Enhancement of chemotherapy by manipulation of tumour pH. Br J Cancer\u20081999; 80: 1005\u201311.","DOI":"10.1038\/sj.bjc.6690455"},{"key":"2022061623331878100_B2","doi-asserted-by":"crossref","unstructured":"Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer\u20082004; 4: 891\u20139.","DOI":"10.1038\/nrc1478"},{"key":"2022061623331878100_B3","unstructured":"Gatenby RA, Gawlinski ET. The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models. Cancer Res\u20082003; 63: 3847\u201354."},{"key":"2022061623331878100_B4","doi-asserted-by":"crossref","unstructured":"Sennoune SR, Luo D, Martinez-Zaguilan R. Plasmalemmal vacuolar-type H+-ATPase in cancer biology. Cell Biochem Biophys\u20082004; 40: 185\u2013206.","DOI":"10.1385\/CBB:40:2:185"},{"key":"2022061623331878100_B5","doi-asserted-by":"crossref","unstructured":"De Milito A, Fais S. Tumor Acidity, Chemoresistance and proton pump inhibitors. Future Oncology\u20082005; 1: 779\u201386.","DOI":"10.2217\/14796694.1.6.779"},{"key":"2022061623331878100_B6","doi-asserted-by":"crossref","unstructured":"Saitoh O, Wang WC, Lotan R, Fukuda M. Differential glycosylation and cell surface expression of lysosomal membrane glycoproteins in sublines of a human colon cancer exhibiting distinct metastatic potentials. J Biol Chem\u20081992; 267: 5700\u201311.","DOI":"10.1016\/S0021-9258(18)42823-2"},{"key":"2022061623331878100_B7","doi-asserted-by":"crossref","unstructured":"Glunde K, Guggino SE, Solaiyappan M, Pathak AP, Ichikawa Y, Bhujwalla ZM. Extracellular acidification alters lysosomal trafficking in human breast cancer cells. Neoplasia\u20082003; 5: 533\u201345.","DOI":"10.1016\/S1476-5586(03)80037-4"},{"key":"2022061623331878100_B8","doi-asserted-by":"crossref","unstructured":"Nishi T, Forgac M. The vacuolar (H+)-ATPases: nature's most versatile proton pumps. Nat Rev Mol Cell Biol\u20082002; 3: 94\u2013103.","DOI":"10.1038\/nrm729"},{"key":"2022061623331878100_B9","doi-asserted-by":"crossref","unstructured":"Vaananen HK, Karhukorpi EK, Sundquist K, et al. Evidence for the presence of a proton pump of the vacuolar H(+)-ATPase type in the ruffled borders of osteoclasts. J Cell Biol\u20081990; 111: 1305\u201311.","DOI":"10.1083\/jcb.111.3.1305"},{"key":"2022061623331878100_B10","doi-asserted-by":"crossref","unstructured":"Marquardt D, Center MS. Involvement of vacuolar H(+)-adenosine triphosphatase activity in multidrug resistance in HL60 cells. J Natl Cancer Inst\u20081991; 83: 1098\u2013102.","DOI":"10.1093\/jnci\/83.15.1098"},{"key":"2022061623331878100_B11","doi-asserted-by":"crossref","unstructured":"Martinez-Zaguilan R, Lynch RM, Martinez GM, Gillies RJ. Vacuolar-type H(+)-ATPases are functionally expressed in plasma membranes of human tumor cells. Am J Physiol\u20081993; 265: C1015\u201329.","DOI":"10.1152\/ajpcell.1993.265.4.C1015"},{"key":"2022061623331878100_B12","doi-asserted-by":"crossref","unstructured":"Murakami T, Shibuya I, Ise T, et al. Elevated expression of vacuolar proton pump genes and cellular PH in cisplatin resistance. Int J Cancer\u20082001; 93: 869\u201374.","DOI":"10.1002\/ijc.1418"},{"key":"2022061623331878100_B13","doi-asserted-by":"crossref","unstructured":"Sennoune SR, Bakunts K, Martinez GM, et al. Vacuolar H+-ATPase in human breast cancer cells with distinct metastatic potential: distribution and functional activity. Am J Physiol Cell Physiol\u20082004; 286: C1443\u201352.","DOI":"10.1152\/ajpcell.00407.2003"},{"key":"2022061623331878100_B14","doi-asserted-by":"crossref","unstructured":"Nishihara T, Akifusa S, Koseki T, Kato S, Muro M, Hanada N. Specific inhibitors of vacuolar type H(+)-ATPases induce apoptotic cell death. Biochem Biophys Res Commun\u20081995; 212: 255\u201362.","DOI":"10.1006\/bbrc.1995.1964"},{"key":"2022061623331878100_B15","doi-asserted-by":"crossref","unstructured":"Lu X, Qin W, Li J, et al. The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump. Cancer Res\u20082005; 65: 6843\u20139.","DOI":"10.1158\/0008-5472.CAN-04-3822"},{"key":"2022061623331878100_B16","doi-asserted-by":"crossref","unstructured":"Chessells JM. Recent advances in management of acute leukaemia. Arch Dis Child\u20082000; 82: 438\u201342.","DOI":"10.1136\/adc.82.6.438"},{"key":"2022061623331878100_B17","doi-asserted-by":"crossref","unstructured":"Kasamon YL, Swinnen LJ. Treatment advances in adult Burkitt lymphoma and leukemia. Curr Opin Oncol\u20082004; 16: 429\u201335.","DOI":"10.1097\/00001622-200409000-00003"},{"key":"2022061623331878100_B18","doi-asserted-by":"crossref","unstructured":"Nilsson A, De Milito A, Engstrom P, et al. Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens. Pediatrics\u20082002; 109: e91.","DOI":"10.1542\/peds.109.6.e91"},{"key":"2022061623331878100_B19","doi-asserted-by":"crossref","unstructured":"Der G. An overview of proton pump inhibitors. Gastroenterol Nurs\u20082003; 26: 182\u201390.","DOI":"10.1097\/00001610-200309000-00003"},{"key":"2022061623331878100_B20","doi-asserted-by":"crossref","unstructured":"Martin de Argila C. Safety of potent gastric acid inhibition. Drugs\u20082005; 65 Suppl 1: 97\u2013104.","DOI":"10.2165\/00003495-200565001-00013"},{"key":"2022061623331878100_B21","doi-asserted-by":"crossref","unstructured":"Mattsson JP, Vaananen K, Wallmark B, Lorentzon P. Omeprazole and bafilomycin, two proton pump inhibitors: differentiation of their effects on gastric, kidney and bone H(+)-translocating ATPases. Biochim Biophys Acta\u20081991; 1065: 261\u20138.","DOI":"10.1016\/0005-2736(91)90238-4"},{"key":"2022061623331878100_B22","doi-asserted-by":"crossref","unstructured":"Moriyama Y, Patel V, Ueda I, Futai M. Evidence for a common binding site for omeprazole and N-ethylmaleimide in subunit A of chromaffin granule vacuolar-type H(+)-ATPase. Biochem Biophys Res Commun\u20081993; 196: 699\u2013706.","DOI":"10.1006\/bbrc.1993.2306"},{"key":"2022061623331878100_B23","doi-asserted-by":"crossref","unstructured":"Sabolic I, Brown D, Verbavatz JM, Kleinman J. H(+)-ATPases of renal cortical and medullary endosomes are differentially sensitive to Sch-28080 and omeprazole. Am J Physiol\u20081994; 266: F868\u201377.","DOI":"10.1152\/ajprenal.1994.266.6.F868"},{"key":"2022061623331878100_B24","doi-asserted-by":"crossref","unstructured":"Luciani F, Spada M, De Milito A, et al. Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. J Natl Cancer Inst\u20082004; 96: 1702\u201313.","DOI":"10.1093\/jnci\/djh305"},{"key":"2022061623331878100_B25","doi-asserted-by":"crossref","unstructured":"Martinez-Zaguilan R, Raghunand N, Lynch RM, et al. pH and drug resistance. I. Functional expression of plasmalemmal V-type H+-ATPase in drug-resistant human breast carcinoma cell lines. Biochem Pharmacol\u20081999; 57: 1037\u201346.","DOI":"10.1016\/S0006-2952(99)00022-2"},{"key":"2022061623331878100_B26","doi-asserted-by":"crossref","unstructured":"Nilsson A, de Milito A, Mowafi F, et al. Expression of CD27-70 on early B cell progenitors in the bone marrow: implication for diagnosis and therapy of childhood ALL. Exp Hematol\u20082005; 33: 1500\u20137.","DOI":"10.1016\/j.exphem.2005.10.005"},{"key":"2022061623331878100_B27","doi-asserted-by":"crossref","unstructured":"Boya P, Andreau K, Poncet D, et al. Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J Exp Med\u20082003; 197: 1323\u201334.","DOI":"10.1084\/jem.20021952"},{"key":"2022061623331878100_B28","doi-asserted-by":"crossref","unstructured":"Lin HJ, Herman P, Kang JS, Lakowicz JR. Fluorescence lifetime characterization of novel low-pH probes. Anal Biochem\u20082001; 294: 118\u201325.","DOI":"10.1006\/abio.2001.5155"},{"key":"2022061623331878100_B29","doi-asserted-by":"crossref","unstructured":"Nilsson C, Kagedal K, Johansson U, Ollinger K. Analysis of cytosolic and lysosomal pH in apoptotic cells by flow cytometry. Methods Cell Sci\u20082003; 25: 185\u201394.","DOI":"10.1007\/s11022-004-8228-3"},{"key":"2022061623331878100_B30","doi-asserted-by":"crossref","unstructured":"Marches R, Vitetta ES, Uhr JW. A role for intracellular pH in membrane IgM-mediated cell death of human B lymphomas. Proc Natl Acad Sci U S A\u20082001; 98: 3434\u20139.","DOI":"10.1073\/pnas.061028998"},{"key":"2022061623331878100_B31","doi-asserted-by":"crossref","unstructured":"Lugli E, Troiano L, Ferraresi R, et al. Characterization of cells with different mitochondrial membrane potential during apoptosis. Cytometry A\u20082005; 68: 28\u201335.","DOI":"10.1002\/cyto.a.20188"},{"key":"2022061623331878100_B32","doi-asserted-by":"crossref","unstructured":"Pui CH, Evans WE. Acute lymphoblastic leukemia. N Engl J Med\u20081998; 339: 605\u201315.","DOI":"10.1056\/NEJM199808273390907"},{"key":"2022061623331878100_B33","doi-asserted-by":"crossref","unstructured":"Horn J. The proton-pump inhibitors: similarities and differences. Clin Ther\u20082000; 22: 266\u201380; discussion 5.","DOI":"10.1016\/S0149-2918(00)80032-6"},{"key":"2022061623331878100_B34","doi-asserted-by":"crossref","unstructured":"Kroemer G, Jaattela M. Lysosomes and autophagy in cell death control. Nat Rev Cancer\u20082005; 5: 886\u201397.","DOI":"10.1038\/nrc1738"},{"key":"2022061623331878100_B35","doi-asserted-by":"crossref","unstructured":"Nakashima S, Hiraku Y, Tada-Oikawa S, et al. Vacuolar H+-ATPase inhibitor induces apoptosis via lysosomal dysfunction in the human gastric cancer cell line MKN-1. J Biochem (Tokyo)\u20082003; 134: 359\u201364.","DOI":"10.1093\/jb\/mvg153"},{"key":"2022061623331878100_B36","doi-asserted-by":"crossref","unstructured":"Scaringi L, Cornacchione P, Ayroldi E, et al. Omeprazole induces apoptosis in Jurkat cells. Int J Immunopathol Pharmacol\u20082004; 17: 331\u201342.","DOI":"10.1177\/039463200401700313"},{"key":"2022061623331878100_B37","doi-asserted-by":"crossref","unstructured":"Rich IN, Worthington-White D, Garden OA, Musk P. Apoptosis of leukemic cells accompanies reduction in intracellular pH after targeted inhibition of the Na(+)\/H(+) exchanger. Blood\u20082000; 95: 1427\u201334.","DOI":"10.1182\/blood.V95.4.1427.004k48_1427_1434"},{"key":"2022061623331878100_B38","doi-asserted-by":"crossref","unstructured":"Nilsson C, Johansson U, Johansson AC, Kagedal K, Ollinger K. Cytosolic acidification and lysosomal alkalinization during TNF-alpha induced apoptosis in U937 cells. Apoptosis\u20082006; 11: 1149\u201359.","DOI":"10.1007\/s10495-006-7108-5"},{"key":"2022061623331878100_B39","unstructured":"Dai H, Kramer DL, Yang C, Murti KG, Porter CW, Cleveland JL. The polyamine oxidase inhibitor MDL-72,527 selectively induces apoptosis of transformed hematopoietic cells through lysosomotropic effects. Cancer Res\u20081999; 59: 4944\u201354."},{"key":"2022061623331878100_B40","doi-asserted-by":"crossref","unstructured":"Zang Y, Beard RL, Chandraratna RA, Kang JX. Evidence of a lysosomal pathway for apoptosis induced by the synthetic retinoid CD437 in human leukemia HL-60 cells. Cell Death Differ\u20082001; 8: 477\u201385.","DOI":"10.1038\/sj.cdd.4400843"},{"key":"2022061623331878100_B41","doi-asserted-by":"crossref","unstructured":"Bellosillo B, Villamor N, Lopez-Guillermo A, et al. Complement-mediated cell death induced by rituximab in B-cell lymphoproliferative disorders is mediated in vitro by a caspase-independent mechanism involving the generation of reactive oxygen species. Blood\u20082001; 98: 2771\u20137.","DOI":"10.1182\/blood.V98.9.2771"},{"key":"2022061623331878100_B42","unstructured":"Katashima M, Yamamoto K, Sugiura M, Sawada Y, Iga T. Comparative pharmacokinetic\/pharmacodynamic study of proton pump inhibitors, omeprazole and lansoprazole in rats. Drug Metab Dispos\u20081995; 23: 718\u201323."},{"key":"2022061623331878100_B43","doi-asserted-by":"crossref","unstructured":"Lugini L, Matarrese P, Tinari A, et al. Cannibalism of live lymphocytes by human metastatic but not primary melanoma cells. Cancer Res\u20082006; 66: 3629\u201338.","DOI":"10.1158\/0008-5472.CAN-05-3204"},{"key":"2022061623331878100_B44","doi-asserted-by":"crossref","unstructured":"Izumi H, Torigoe T, Ishiguchi H, et al. Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy. Cancer Treat Rev\u20082003; 29: 541\u20139.","DOI":"10.1016\/S0305-7372(03)00106-3"},{"key":"2022061623331878100_B45","doi-asserted-by":"crossref","unstructured":"De Milito A, Fais S. Proton pump inhibitors may reduce tumour resistance. Expert Opin Pharmacother\u20082005; 6: 1049\u201354.","DOI":"10.1517\/14656566.6.7.1049"},{"key":"2022061623331878100_B46","doi-asserted-by":"crossref","unstructured":"Kountouras J, Boura P, Apostolides G, Zaharioudaki E, Tsapas G. In vivo effect of omeprazole on HLA-DR expression and the monocyte-macrophage function in patients with duodenal ulcer disease. Immunopharmacol Immunotoxicol\u20081994; 16: 437\u201348.","DOI":"10.3109\/08923979409007103"},{"key":"2022061623331878100_B47","doi-asserted-by":"crossref","unstructured":"Sjostrom JE, Kuhler T, Larsson H. Basis for the selective antibacterial activity in vitro of proton pump inhibitors against Helicobacter spp. Antimicrob Agents Chemother\u20081997; 41: 1797\u2013801.","DOI":"10.1128\/AAC.41.8.1797"},{"key":"2022061623331878100_B48","doi-asserted-by":"crossref","unstructured":"Jiang S, Meadows J, Anderson SA, Mukkada AJ. Antileishmanial activity of the antiulcer agent omeprazole. Antimicrob Agents Chemother\u20082002; 46: 2569\u201374.","DOI":"10.1128\/AAC.46.8.2569-2574.2002"},{"key":"2022061623331878100_B49","doi-asserted-by":"crossref","unstructured":"Carlo-Stella C, Di Nicola M, Turco MC, et al. The anti-human leukocyte antigen-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing nonobese diabetic\/severe combined immunodeficient mice. Cancer Res\u20082006; 66: 1799\u2013808.","DOI":"10.1158\/0008-5472.CAN-05-1200"},{"key":"2022061623331878100_B50","doi-asserted-by":"crossref","unstructured":"Cregan SP, Dawson VL, Slack RS. Role of AIF in caspase-dependent and caspase-independent cell death. Oncogene\u20082004; 23: 2785\u201396.","DOI":"10.1038\/sj.onc.1207517"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/11\/5408\/2863040\/5408.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/11\/5408\/2863040\/5408.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T23:38:22Z","timestamp":1655422702000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/11\/5408\/533209\/Proton-Pump-Inhibitors-Induce-Apoptosis-of-Human-B"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,1]]},"references-count":50,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2007,6,1]]},"published-print":{"date-parts":[[2007,6,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-4095","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6495983","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6495983.v1","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22368500","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22368497","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22368497.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22368500.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,1]]}}}